FDA Panel Votes Down Two Cancer Drugs

(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee voiced near unanimous disapproval for a novel advanced renal cell carcinoma drug and a drug-device combo to treat unresectable ocular melanoma that is metastatic to the liver.
Source: MedPage Today Public Health - Category: American Health Source Type: news